TGFB1 and cancer: Cancer cells in turn promote OB/MSC production of more RANKL to enhance OC formation, causing osteolysis11,15,16 and release of factors from bone matrix, including TGFβ, which can inhibit OB formation17 and OB-mediated repair of lytic lesions7,8.